RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 83 filers reported holding RAPT THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $31,921,336 | -25.4% | 1,920,658 | -16.1% | 1.06% | -14.0% |
Q2 2023 | $42,794,819 | +1.8% | 2,288,493 | -0.1% | 1.24% | -0.2% |
Q1 2023 | $42,051,007 | +18.1% | 2,291,608 | +27.4% | 1.24% | +24.2% |
Q4 2022 | $35,619,309 | -13.6% | 1,798,955 | +5.0% | 1.00% | -16.4% |
Q3 2022 | $41,218,000 | +18.0% | 1,713,134 | -10.5% | 1.20% | +9.3% |
Q2 2022 | $34,927,000 | -43.3% | 1,913,791 | -31.6% | 1.09% | -11.3% |
Q1 2022 | $61,571,000 | -71.4% | 2,799,962 | -52.2% | 1.23% | -25.7% |
Q4 2021 | $215,058,000 | +138.2% | 5,855,130 | +101.4% | 1.66% | +26.5% |
Q3 2021 | $90,280,000 | -42.7% | 2,907,565 | -42.3% | 1.31% | +28.2% |
Q2 2021 | $157,568,000 | +186.5% | 5,041,320 | +103.5% | 1.02% | +47.0% |
Q1 2021 | $55,000,000 | +76.5% | 2,477,481 | +57.1% | 0.70% | +108.4% |
Q4 2020 | $31,155,000 | – | 1,577,481 | – | 0.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Column Group LLC | 2,680,621 | $49,189,395 | 17.79% |
Euclidean Capital LLC | 432,900 | $7,943,715 | 6.97% |
GREAT POINT PARTNERS LLC | 1,355,151 | $24,867,021 | 4.88% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 875,984 | $16,074,306 | 3.02% |
Trustees of Columbia University in the City of New York | 80,580 | $1,478,643 | 2.64% |
Perceptive Advisors | 2,291,608 | $42,051,007 | 1.24% |
Cormorant Asset Management, LP | 650,000 | $11,928 | 0.79% |
Alphabet Inc. | 540,270 | $9,913,955 | 0.55% |
Redmile Group, LLC | 688,132 | $12,627,222 | 0.55% |
Orbimed Advisors | 1,251,070 | $22,957,135 | 0.45% |